SNN
USDSmith & Nephew SNATS Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$36.480
Haut
$37.080
Bas
$36.460
Volume
1.61M
Fondamentaux de l'Entreprise
Capitalisation Boursière
15.8B
Industrie
Dispositifs médicaux
Pays
United Kingdom
Statistiques de Trading
Volume Moyen
0.67M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices
UFC® and Smith+Nephew announce multi-year extension of partnership
Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts organization, have
Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target
Bernstein analyst Lisa Clive downgrades Smith & Nephew from Outperform to Market Perform and announces $37.5 price target.
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.